{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:38:34Z","timestamp":1791499114712,"version":"4.3.4"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health ~ Holland"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In Alzheimer\u2019s disease (AD), MRI atrophy patterns can distinguish between amnestic (typical) and non-amnestic (atypical) clinical phenotypes and are increasingly used for diagnosis and outcome measures in clinical trials. However, understanding how protein accumulation and other key features of neurodegeneration influence these imaging measurements, are lacking. The current study aimed to assess regional MRI patterns of cortical atrophy across clinical AD phenotypes, and their association with amyloid-beta (A\u03b2), phosphorylated tau (pTau), neuro-axonal degeneration and microvascular deterioration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Post-mortem\n                      <jats:italic>in-situ<\/jats:italic>\n                      3DT1 3\u2009T-MRI data was obtained from 33 AD (17 typical, 16 atypical) and 16 control brain donors. Additionally, ante-mortem 3DT1 3\u2009T-MRI scans of brain donors were collected if available. Regional volumes were obtained from MRI scans using an atlas based parcellation software. Eight cortical brain regions were selected from formalin-fixed right hemispheres of brain donors and then immunostained for A\u03b2, pTau, neurofilament light, and collagen IV. Group comparisons and volume-pathology associations were analyzed using linear mixed models corrected for age, sex, post-mortem delay, and intracranial volume.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to controls, both typical and atypical AD showed volume loss in the temporo-occipital cortex, while typical AD showed additional volume loss in the parietal cortex. Posterior cingulate volume was lower in typical AD compared to atypical AD (- 6.9%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009= 0.043). In AD, a global positive association between MRI cortical volume and A\u03b2 load (\u03b2s =\u20090.21,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009= 0.010), and a global negative association with NfL load (\u03b2s =\u2009- 0.18,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009= 0.018) were observed. Regionally, higher superior parietal gyrus volume was associated with higher A\u03b2 load in typical AD (\u03b2s =\u20090.47,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009= 0.004), lower middle frontal gyrus volume associated with higher NfL load in atypical AD (\u03b2s =\u2009- 0.50,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt; 0.001), and lower hippocampal volume associated with higher COLIV load in typical AD (\u03b2s =\u2009- 1.69,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt; 0.001). Comparing post-mortem with ante-mortem scans showed minimal volume differences at scan-intervals within 2 years, highlighting the translational aspect of this study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For both clinical phenotypes, cortical volume is affected by A\u03b2 and neuro-axonal damage, but in opposing directions. Differences in volume-pathology relationships between clinical phenotypes are region-specific. The findings of this study could improve the interpretation of MRI datasets in heterogenous AD cohorts, both in research and clinical settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-025-01727-5","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T20:46:55Z","timestamp":1745614015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical phenotypes of Alzheimer\u2019s disease: investigating atrophy patterns and their pathological correlates"],"prefix":"10.1186","volume":"17","author":[{"given":"Niels","family":"Reijner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Frigerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M. A.","family":"Bouwman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. D. C.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Guizard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Jubault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J. M.","family":"Hoozemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J. M.","family":"Rozemuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. H.","family":"Bouwman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Barkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. D. J.","family":"van de Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. E.","family":"Jonkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"key":"1727_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","volume":"30","author":"L Pini","year":"2016","unstructured":"Pini L, Pievani M, Bocchetta M, Altomare D, Bosco P, Cavedo E, et al. Brain atrophy in Alzheimer\u2019s disease and aging. Ageing Res Rev. 2016;30:25\u201348.","journal-title":"Ageing Res Rev"},{"issue":"10284","key":"1727_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen CE, et al. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u201390.","journal-title":"Lancet"},{"issue":"8","key":"1727_CR3","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734\u201346.","journal-title":"Lancet Neurol"},{"issue":"8","key":"1727_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.jalz.2018.02.020","volume":"14","author":"JL Whitwell","year":"2018","unstructured":"Whitwell JL, Graff-Radford J, Tosakulwong N, Weigand SD, Machulda MM, Senjem ML, et al. Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(8):1005\u201314.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1727_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/S1474-4422(20)30440-3","volume":"20","author":"J Graff-Radford","year":"2021","unstructured":"Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, et al. New insights into atypical Alzheimer\u2019s disease in the era of biomarkers. Lancet Neurol. 2021;20(3):222\u201334.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1727_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jamaneurol.2021.4417","volume":"79","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, Singleton EH, Groot C, Dijkstra AA, Eikelboom WS, Seeley WW, et al. Research criteria for the behavioral variant of Alzheimer disease: a systematic review and meta-analysis. JAMA Neurol. 2022;79(1):48\u201360.","journal-title":"JAMA Neurol"},{"issue":"1","key":"1727_CR7","doi-asserted-by":"publisher","first-page":"fcaa068","DOI":"10.1093\/braincomms\/fcaa068","volume":"2","author":"RA Townley","year":"2020","unstructured":"Townley RA, Graff-Radford J, Mantyh WG, Botha H, Polsinelli AJ, Przybelski SA, et al. Progressive dysexecutive syndrome due to Alzheimer\u2019s disease: a description of 55 cases and comparison to other phenotypes. Brain Commun. 2020;2(1):fcaa068.","journal-title":"Brain Commun"},{"issue":"2","key":"1727_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(11)70289-7","volume":"11","author":"SJ Crutch","year":"2012","unstructured":"Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. Lancet Neurol. 2012;11(2):170\u20138.","journal-title":"Lancet Neurol"},{"issue":"13","key":"1727_CR9","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1212\/WNL.0000000000003165","volume":"87","author":"E Rogalski","year":"2016","unstructured":"Rogalski E, Sridhar J, Rader B, Martersteck A, Chen K, Cobia D, et al. Aphasic variant of Alzheimer disease: clinical, anatomic, and genetic features. Neurology. 2016;87(13):1337\u201343.","journal-title":"Neurology"},{"issue":"Pt 9","key":"1727_CR10","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1093\/brain\/awv191","volume":"138","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, Vogel JW, et al. The behavioural\/dysexecutive variant of Alzheimer\u2019s disease: clinical, neuroimaging and pathological features. Brain. 2015;138(Pt 9):2732\u201349.","journal-title":"Brain"},{"issue":"10","key":"1727_CR11","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.1002\/alz.13396","volume":"19","author":"I Sintini","year":"2023","unstructured":"Sintini I, Graff-Radford J, Schwarz CG, Machulda MM, Singh NA, Carlos AF, et al. Longitudinal rates of atrophy and tau accumulation differ between the visual and language variants of atypical Alzheimer\u2019s disease. Alzheimers Dement. 2023;19(10):4396\u2013406.","journal-title":"Alzheimers Dement"},{"issue":"Pt 5","key":"1727_CR12","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Scholl M, Lockhart SN, Ayakta N, Baker SL, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain. 2016;139(Pt 5):1551\u201367.","journal-title":"Brain"},{"issue":"1","key":"1727_CR13","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1212\/WNL.0000000000011081","volume":"96","author":"J Therriault","year":"2021","unstructured":"Therriault J, Pascoal TA, Savard M, Benedet AL, Chamoun M, Tissot C, et al. Topographic distribution of amyloid-beta, Tau, and atrophy in patients with behavioral\/dysexecutive Alzheimer disease. Neurology. 2021;96(1):e81\u201392.","journal-title":"Neurology"},{"issue":"8","key":"1727_CR14","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuint.2013.08.013","volume":"63","author":"WM Alobuia","year":"2013","unstructured":"Alobuia WM, Xia W, Vohra BP. Axon degeneration is key component of neuronal death in amyloid-beta toxicity. Neurochem Int. 2013;63(8):782\u20139.","journal-title":"Neurochem Int"},{"key":"1727_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.581767","volume":"12","author":"N Salvadores","year":"2020","unstructured":"Salvadores N, Geronimo-Olvera C, Court FA. Axonal degeneration in AD: the contribution of abeta and Tau. Front Aging Neurosci. 2020;12: 581767.","journal-title":"Front Aging Neurosci"},{"key":"1727_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00451","volume":"11","author":"N Salvadores","year":"2017","unstructured":"Salvadores N, Sanhueza M, Manque P, Court FA. Axonal degeneration during aging and its functional role in neurodegenerative disorders. Front Neurosci. 2017;11: 451.","journal-title":"Front Neurosci"},{"issue":"1","key":"1727_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13195-022-01081-w","volume":"14","author":"AL Svenningsson","year":"2022","unstructured":"Svenningsson AL, Stomrud E, Palmqvist S, Hansson O, Ossenkoppele R. Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy. Alzheimers Res Ther. 2022;14(1):144.","journal-title":"Alzheimers Res Ther"},{"issue":"11","key":"1727_CR18","doi-asserted-by":"publisher","first-page":"e168554","DOI":"10.1172\/JCI168554","volume":"133","author":"SH Berth","year":"2023","unstructured":"Berth SH, Lloyd TE. Disruption of axonal transport in neurodegeneration. J Clin Invest. 2023;133(11):e168554.","journal-title":"J Clin Invest"},{"issue":"10","key":"1727_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M, Piehl F, Sormani MP, Gattringer T, et al. Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol. 2018;14(10):577\u201389.","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"1727_CR20","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/jnr.24482","volume":"97","author":"S Lee","year":"2019","unstructured":"Lee S, Eyer J, Letournel F, Boumil E, Hall G, Shea TB. Neurofilaments form flexible bundles during neuritogenesis in culture and in mature axons in situ. J Neurosci Res. 2019;97(10):1306\u201318.","journal-title":"J Neurosci Res"},{"issue":"1","key":"1727_CR21","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","volume":"12","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Janelidze S, Al Khleifat A, Leuzy A, van der Ende EL, Karikari TK, et al. A multicentre validation study of the diagnostic value of plasma neurofilament light. Nat Commun. 2021;12(1):3400.","journal-title":"Nat Commun"},{"issue":"10","key":"1727_CR22","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.1038\/s41380-020-0818-1","volume":"26","author":"MS Kang","year":"2021","unstructured":"Kang MS, Aliaga AA, Shin M, Mathotaarachchi S, Benedet AL, Pascoal TA, et al. Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer\u2019s disease. Mol Psychiatry. 2021;26(10):5989\u20136001.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"1727_CR23","volume":"12","author":"K Dhiman","year":"2020","unstructured":"Dhiman K, Gupta VB, Villemagne VL, Eratne D, Graham PL, Fowler C, et al. Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer\u2019s disease. Alzheimers Dement (Amst). 2020;12(1): e12005.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"12","key":"1727_CR24","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1007\/s00415-015-7904-3","volume":"262","author":"RW Paterson","year":"2015","unstructured":"Paterson RW, Toombs J, Slattery CF, Nicholas JM, Andreasson U, Magdalinou NK, et al. Dissecting IWG-2 typical and atypical Alzheimer\u2019s disease: insights from cerebrospinal fluid analysis. J Neurol. 2015;262(12):2722\u201330.","journal-title":"J Neurol"},{"issue":"1","key":"1727_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways. Nat Rev Neurol. 2020;16(1):30\u201342.","journal-title":"Nat Rev Neurol"},{"key":"1727_CR26","doi-asserted-by":"publisher","first-page":"618986","DOI":"10.3389\/fncel.2020.618986","volume":"14","author":"J Steinman","year":"2020","unstructured":"Steinman J, Sun HS, Feng ZP. Microvascular Alterations in Alzheimer\u2019s Disease. Front Cell Neurosci. 2020;14:618986.","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"1727_CR27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3233\/JAD-2010-100849","volume":"22","author":"E Richard","year":"2010","unstructured":"Richard E, van Gool WA, Hoozemans JJ, van Haastert ES, Eikelenboom P, Rozemuller AJ, et al. Morphometric changes in the cortical microvascular network in Alzheimer\u2019s disease. J Alzheimers Dis. 2010;22(3):811\u20138.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"1727_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036893","volume":"7","author":"JM Hunter","year":"2012","unstructured":"Hunter JM, Kwan J, Malek-Ahmadi M, Maarouf CL, Kokjohn TA, Belden C, et al. Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer\u2019s disease. PLoS ONE. 2012;7(5): e36893.","journal-title":"PLoS ONE"},{"issue":"3","key":"1727_CR29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3233\/JAD-170850","volume":"62","author":"WM van der Flier","year":"2018","unstructured":"van der Flier WM, Scheltens P. Amsterdam dementia cohort: performing research to optimize care. J Alzheimers Dis. 2018;62(3):1091\u2013111.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1727_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3233\/JAD-132306","volume":"41","author":"WM van der Flier","year":"2014","unstructured":"van der Flier WM, Pijnenburg YA, Prins N, Lemstra AW, Bouwman FH, Teunissen CE, et al. Optimizing patient care and research: the Amsterdam Dementia Cohort. J Alzheimers Dis. 2014;41(1):313\u201327.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"1727_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/nen.0b013e3181633526","volume":"67","author":"I Alafuzoff","year":"2008","unstructured":"Alafuzoff I, Parkkinen L, Al-Sarraj S, Arzberger T, Bell J, Bodi I, et al. Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol. 2008;67(2):125\u201343.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"1727_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00401-009-0485-4","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff I, Thal DR, Arzberger T, Bogdanovic N, Al-Sarraj S, Bodi I, et al. Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol. 2009;117(3):309\u201320.","journal-title":"Acta Neuropathol"},{"key":"1727_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101698","volume":"22","author":"LE Jonkman","year":"2019","unstructured":"Jonkman LE, Graaf YG, Bulk M, Kaaij E, Pouwels PJW, Barkhof F, et al. Normal Aging Brain Collection Amsterdam (NABCA): A comprehensive collection of postmortem high-field imaging, neuropathological and morphometric datasets of non-neurological controls. Neuroimage Clin. 2019;22: 101698.","journal-title":"Neuroimage Clin"},{"issue":"5","key":"1727_CR34","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1007\/s00330-021-08385-9","volume":"32","author":"E Cavedo","year":"2022","unstructured":"Cavedo E, Tran P, Thoprakarn U, Martini JB, Movschin A, Delmaire C, et al. Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore(R). Eur Radiol. 2022;32(5):2949\u201361.","journal-title":"Eur Radiol"},{"key":"1727_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.102940","volume":"33","author":"P Tran","year":"2022","unstructured":"Tran P, Thoprakarn U, Gourieux E, Dos Santos CL, Cavedo E, Guizard N, et al. Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects. Neuroimage Clin. 2022;33: 102940.","journal-title":"Neuroimage Clin"},{"issue":"3","key":"1727_CR36","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.neuroimage.2009.02.013","volume":"46","author":"M Chupin","year":"2009","unstructured":"Chupin M, Hammers A, Liu RS, Colliot O, Burdett J, Bardinet E, et al. Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: method and validation. Neuroimage. 2009;46(3):749\u201361.","journal-title":"Neuroimage"},{"key":"1727_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2019.116189","volume":"206","author":"ET Rolls","year":"2020","unstructured":"Rolls ET, Huang CC, Lin CP, Feng J, Joliot M. Automated anatomical labelling atlas 3. Neuroimage. 2020;206: 116189.","journal-title":"Neuroimage"},{"issue":"5","key":"1727_CR38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/bpa.12442","volume":"27","author":"T Arendt","year":"2017","unstructured":"Arendt T, Morawski M, Gartner U, Frohlich N, Schulze F, Wohmann N, et al. Inhomogeneous distribution of Alzheimer pathology along the isocortical relief. Are cortical convolutions an Achilles heel of evolution? Brain Pathol. 2017;27(5):603\u201311.","journal-title":"Brain Pathol"},{"key":"1727_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.neuroimage.2013.08.067","volume":"84","author":"DH Adler","year":"2014","unstructured":"Adler DH, Pluta J, Kadivar S, Craige C, Gee JC, Avants BB, et al. Histology-derived volumetric annotation of the human hippocampal subfields in postmortem MRI. Neuroimage. 2014;84:505\u201323.","journal-title":"Neuroimage"},{"key":"1727_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fnana.2017.00084","volume":"11","author":"R Insausti","year":"2017","unstructured":"Insausti R, Munoz-Lopez M, Insausti AM, Artacho-Perula E. The human periallocortex: layer pattern in presubiculum, parasubiculum and entorhinal cortex. A Review Front Neuroanat. 2017;11:84.","journal-title":"A Review Front Neuroanat"},{"issue":"7","key":"1727_CR41","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u201382.","journal-title":"Nat Methods"},{"issue":"8","key":"1727_CR42","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/jnen\/59.8.733","volume":"59","author":"DR Thal","year":"2000","unstructured":"Thal DR, Rub U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K, et al. Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol. 2000;59(8):733\u201348.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"1727_CR43","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-020-02198-8","volume":"140","author":"BDC Boon","year":"2020","unstructured":"Boon BDC, Bulk M, Jonker AJ, Morrema THJ, van den Berg E, Popovic M, et al. The coarse-grained plaque: a divergent Abeta plaque-type in early-onset Alzheimer\u2019s disease. Acta Neuropathol. 2020;140(6):811\u201330.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1727_CR44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology. 1991;41(4):479\u201386.","journal-title":"Neurology"},{"issue":"2","key":"1727_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016;15(2):155\u201363.","journal-title":"J Chiropr Med"},{"issue":"3\u20134","key":"1727_CR46","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12640-010-9175-1","volume":"18","author":"JL Whitwell","year":"2010","unstructured":"Whitwell JL. Progression of atrophy in Alzheimer\u2019s disease and related disorders. Neurotox Res. 2010;18(3\u20134):339\u201346.","journal-title":"Neurotox Res"},{"issue":"3","key":"1727_CR47","doi-asserted-by":"publisher","first-page":"fcac109","DOI":"10.1093\/braincomms\/fcac109","volume":"4","author":"V Planche","year":"2022","unstructured":"Planche V, Manjon JV, Mansencal B, Lanuza E, Tourdias T, Catheline G, et al. Structural progression of Alzheimer\u2019s disease over decades: the MRI staging scheme. Brain Commun. 2022;4(3):fcac109.","journal-title":"Brain Commun"},{"key":"1727_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1746-1596-6-105","volume":"6","author":"A Farzan","year":"2011","unstructured":"Farzan A, Mashohor S, Ramli R, Mahmud R. Discriminant analysis of intermediate brain atrophy rates in longitudinal diagnosis of Alzheimer\u2019s disease. Diagn Pathol. 2011;6:105.","journal-title":"Diagn Pathol"},{"key":"1727_CR49","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3389\/fnins.2016.00582","volume":"10","author":"J Mutlu","year":"2016","unstructured":"Mutlu J, Landeau B, Tomadesso C, de Flores R, Mezenge F, de La Sayette V, et al. Connectivity Disruption, Atrophy, and Hypometabolism within Posterior Cingulate Networks in Alzheimer\u2019s Disease. Front Neurosci. 2016;10:582.","journal-title":"Front Neurosci"},{"issue":"1","key":"1727_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2008.03.014","volume":"31","author":"G Pengas","year":"2010","unstructured":"Pengas G, Hodges JR, Watson P, Nestor PJ. Focal posterior cingulate atrophy in incipient Alzheimer\u2019s disease. Neurobiol Aging. 2010;31(1):25\u201333.","journal-title":"Neurobiol Aging"},{"issue":"34","key":"1727_CR51","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","volume":"25","author":"RL Buckner","year":"2005","unstructured":"Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, et al. Molecular, structural, and functional characterization of Alzheimer\u2019s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25(34):7709\u201317.","journal-title":"J Neurosci"},{"issue":"10","key":"1727_CR52","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41583-023-00731-8","volume":"24","author":"JW Vogel","year":"2023","unstructured":"Vogel JW, Corriveau-Lecavalier N, Franzmeier N, Pereira JB, Brown JA, Maass A, et al. Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight. Nat Rev Neurosci. 2023;24(10):620\u201339.","journal-title":"Nat Rev Neurosci"},{"key":"1727_CR53","doi-asserted-by":"publisher","first-page":"101482","DOI":"10.1016\/j.arr.2021.101482","volume":"72","author":"L Pini","year":"2021","unstructured":"Pini L, Wennberg AM, Salvalaggio A, Vallesi A, Pievani M, Corbetta M. Breakdown of specific functional brain networks in clinical variants of Alzheimer\u2019s disease. Ageing Res Rev. 2021;72:101482.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"1727_CR54","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00330-015-3789-x","volume":"26","author":"RM Steketee","year":"2016","unstructured":"Steketee RM, Bron EE, Meijboom R, Houston GC, Klein S, Mutsaerts HJ, et al. Early-stage differentiation between presenile Alzheimer\u2019s disease and frontotemporal dementia using arterial spin labeling MRI. Eur Radiol. 2016;26(1):244\u201353.","journal-title":"Eur Radiol"},{"issue":"7","key":"1727_CR55","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/archneur.60.7.949","volume":"60","author":"AL Boxer","year":"2003","unstructured":"Boxer AL, Rankin KP, Miller BL, Schuff N, Weiner M, Gorno-Tempini ML, et al. Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia. Arch Neurol. 2003;60(7):949\u201356.","journal-title":"Arch Neurol"},{"issue":"5","key":"1727_CR56","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jalz.2016.08.010","volume":"13","author":"J Pegueroles","year":"2017","unstructured":"Pegueroles J, Vilaplana E, Montal V, Sampedro F, Alcolea D, Carmona-Iragui M, et al. Longitudinal brain structural changes in preclinical Alzheimer\u2019s disease. Alzheimers Dement. 2017;13(5):499\u2013509.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"1727_CR57","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ana.24186","volume":"76","author":"J Fortea","year":"2014","unstructured":"Fortea J, Vilaplana E, Alcolea D, Carmona-Iragui M, Sanchez-Saudinos MB, Sala I, et al. Cerebrospinal fluid beta-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease. Ann Neurol. 2014;76(2):223\u201330.","journal-title":"Ann Neurol"},{"issue":"3","key":"1727_CR58","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2013.09.028","volume":"35","author":"SC Johnson","year":"2014","unstructured":"Johnson SC, Christian BT, Okonkwo OC, Oh JM, Harding S, Xu G, et al. Amyloid burden and neural function in people at risk for Alzheimer\u2019s Disease. Neurobiol Aging. 2014;35(3):576\u201384.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"1727_CR59","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/alz.12292","volume":"17","author":"S Ingala","year":"2021","unstructured":"Ingala S, De Boer C, Masselink LA, Vergari I, Lorenzini L, Blennow K, et al. Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort. Alzheimers Dement. 2021;17(7):1189\u2013204.","journal-title":"Alzheimers Dement"},{"key":"1727_CR60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neurobiolaging.2023.05.004","volume":"129","author":"ME Williams","year":"2023","unstructured":"Williams ME, Elman JA, Bell TR, Dale AM, Eyler LT, Fennema-Notestine C, et al. Higher cortical thickness\/volume in Alzheimer\u2019s-related regions: protective factor or risk factor? Neurobiol Aging. 2023;129:185\u201394.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1727_CR61","doi-asserted-by":"publisher","first-page":"fcab281","DOI":"10.1093\/braincomms\/fcab281","volume":"3","author":"I Frigerio","year":"2021","unstructured":"Frigerio I, Boon BDC, Lin CP, Galis-de Graaf Y, Bol J, Preziosa P, et al. Amyloid-beta, p-tau and reactive microglia are pathological correlates of MRI cortical atrophy in Alzheimer\u2019s disease. Brain Commun. 2021;3(4):fcab281.","journal-title":"Brain Commun"},{"issue":"20","key":"1727_CR62","doi-asserted-by":"publisher","first-page":"e2114","DOI":"10.1212\/WNL.0000000000207156","volume":"100","author":"F Alves","year":"2023","unstructured":"Alves F, Kalinowski P, Ayton S. Accelerated Brain Volume Loss Caused by Anti-beta-Amyloid Drugs: A Systematic Review and Meta-analysis. Neurology. 2023;100(20):e2114\u201324.","journal-title":"Neurology"},{"issue":"20","key":"1727_CR63","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1212\/WNL.0000000000207268","volume":"100","author":"F Barkhof","year":"2023","unstructured":"Barkhof F, Knopman DS. Brain Shrinkage in Anti-beta-Amyloid Alzheimer Trials: Neurodegeneration or Pseudoatrophy? Neurology. 2023;100(20):941\u20132.","journal-title":"Neurology"},{"issue":"10","key":"1727_CR64","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S1474-4422(24)00335-1","volume":"23","author":"CRS Belder","year":"2024","unstructured":"Belder CRS, Boche D, Nicoll JAR, Jaunmuktane Z, Zetterberg H, Schott JM, et al. Brain volume change following anti-amyloid beta immunotherapy for Alzheimer\u2019s disease: amyloid-removal-related pseudo-atrophy. Lancet Neurol. 2024;23(10):1025\u201334.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1727_CR65","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/ana.26233","volume":"90","author":"SR Das","year":"2021","unstructured":"Das SR, Lyu X, Duong MT, Xie L, McCollum L, de Flores R, et al. Tau-Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer\u2019s Disease. Ann Neurol. 2021;90(5):751\u201362.","journal-title":"Ann Neurol"},{"issue":"5","key":"1727_CR66","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1212\/WNL.0000000000011272","volume":"96","author":"S Palmqvist","year":"2021","unstructured":"Palmqvist S, Eshaghi A. Spatial Distribution of Tau and beta-Amyloid Pathologies and Their Role in Different Alzheimer Disease Phenotypes. Neurology. 2021;96(5):191\u20132.","journal-title":"Neurology"},{"issue":"3","key":"1727_CR67","doi-asserted-by":"publisher","first-page":"fcac108","DOI":"10.1093\/braincomms\/fcac108","volume":"4","author":"AF Carlos","year":"2022","unstructured":"Carlos AF, Tosakulwong N, Weigand SD, Buciuc M, Ali F, Clark HM, et al. Histologic lesion type correlates of magnetic resonance imaging biomarkers in four-repeat tauopathies. Brain Commun. 2022;4(3):fcac108.","journal-title":"Brain Commun."},{"issue":"9","key":"1727_CR68","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1002\/alz.12321","volume":"17","author":"CM Moloney","year":"2021","unstructured":"Moloney CM, Lowe VJ, Murray ME. Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: A clinicopathologic perspective for biomarker research. Alzheimers Dement. 2021;17(9):1554\u201374.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1727_CR69","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1038\/s41467-024-49205-0","volume":"15","author":"S Ravikumar","year":"2024","unstructured":"Ravikumar S, Denning AE, Lim S, Chung E, Sadeghpour N, Ittyerah R, et al. Postmortem imaging reveals patterns of medial temporal lobe vulnerability to tau pathology in Alzheimer\u2019s disease. Nat Commun. 2024;15(1):4803.","journal-title":"Nat Commun"},{"issue":"3","key":"1727_CR70","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/alz.12749","volume":"19","author":"CM Moloney","year":"2023","unstructured":"Moloney CM, Labuzan SA, Crook JE, Siddiqui H, Castanedes-Casey M, Lachner C, et al. Phosphorylated tau sites that are elevated in Alzheimer\u2019s disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain. Alzheimers Dement. 2023;19(3):1029\u201340.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"1727_CR71","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s00415-018-8825-8","volume":"265","author":"R Opfer","year":"2018","unstructured":"Opfer R, Ostwaldt AC, Walker-Egger C, Manogaran P, Sormani MP, De Stefano N, et al. Within-patient fluctuation of brain volume estimates from short-term repeated MRI measurements using SIENA\/FSL. J Neurol. 2018;265(5):1158\u201365.","journal-title":"J Neurol"},{"issue":"6","key":"1727_CR72","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/alzrt230","volume":"5","author":"WA Jefferies","year":"2013","unstructured":"Jefferies WA, Price KA, Biron KE, Fenninger F, Pfeifer CG, Dickstein DL. Adjusting the compass: new insights into the role of angiogenesis in Alzheimer\u2019s disease. Alzheimers Res Ther. 2013;5(6):64.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"1727_CR73","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00702-009-0226-9","volume":"116","author":"BS Desai","year":"2009","unstructured":"Desai BS, Schneider JA, Li JL, Carvey PM, Hendey B. Evidence of angiogenic vessels in Alzheimer\u2019s disease. J Neural Transm (Vienna). 2009;116(5):587\u201397.","journal-title":"J Neural Transm (Vienna)"},{"issue":"9357","key":"1727_CR74","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0140-6736(03)12521-4","volume":"361","author":"AH Vagnucci Jr","year":"2003","unstructured":"Vagnucci AH Jr, Li WW. Alzheimer\u2019s disease and angiogenesis. Lancet. 2003;361(9357):605\u20138.","journal-title":"Lancet"},{"issue":"1","key":"1727_CR75","doi-asserted-by":"publisher","first-page":"fcz030","DOI":"10.1093\/braincomms\/fcz030","volume":"1","author":"BDC Boon","year":"2019","unstructured":"Boon BDC, Pouwels PJW, Jonkman LE, Keijzer MJ, Preziosa P, van de Berg WDJ, et al. Can post-mortem MRI be used as a proxy for in vivo? A case study. Brain Commun. 2019;1(1):fcz030.","journal-title":"Brain Commun"},{"issue":"6","key":"1727_CR76","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1007\/s00415-024-12297-1","volume":"271","author":"NA Singh","year":"2024","unstructured":"Singh NA, Graff-Radford J, Machulda MM, Carlos AF, Schwarz CG, Senjem ML, et al. Atypical Alzheimer\u2019s disease: new insights into an overlapping spectrum between the language and visual variants. J Neurol. 2024;271(6):3571\u201385.","journal-title":"J Neurol"},{"issue":"24","key":"1727_CR77","doi-asserted-by":"publisher","first-page":"e2436","DOI":"10.1212\/WNL.0000000000200336","volume":"98","author":"JL Whitwell","year":"2022","unstructured":"Whitwell JL, Martin PR, Graff-Radford J, Machulda MM, Sintini I, Buciuc M, et al. Investigating Heterogeneity and Neuroanatomic Correlates of Longitudinal Clinical Decline in Atypical Alzheimer Disease. Neurology. 2022;98(24):e2436\u201345.","journal-title":"Neurology"},{"issue":"5","key":"1727_CR78","doi-asserted-by":"publisher","first-page":"e13009","DOI":"10.1111\/nan.13009","volume":"50","author":"BDC Boon","year":"2024","unstructured":"Boon BDC, Frigerio I, de Gooijer D, Morrema THJ, Bol J, Galis-de Graaf Y, et al. Alzheimer\u2019s disease clinical variants show distinct neuroinflammatory profiles with neuropathology. Neuropathol Appl Neurobiol. 2024;50(5):e13009.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"1727_CR79","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/alz.12582","volume":"18","author":"AP Mecca","year":"2022","unstructured":"Mecca AP, O\u2019Dell RS, Sharp ES, Banks ER, Bartlett HH, Zhao W, et al. Synaptic density and cognitive performance in Alzheimer\u2019s disease: A PET imaging study with [(11) C]UCB-J. Alzheimers Dement. 2022;18(12):2527\u201336.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1727_CR80","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40478-022-01370-3","volume":"10","author":"RN Taddei","year":"2022","unstructured":"Taddei RN, Sanchez-Mico MV, Bonnar O, Connors T, Gaona A, Denbow D, et al. Changes in glial cell phenotypes precede overt neurofibrillary tangle formation, correlate with markers of cortical cell damage, and predict cognitive status of individuals at Braak III-IV stages. Acta Neuropathol Commun. 2022;10(1):72.","journal-title":"Acta Neuropathol Commun"},{"issue":"8026","key":"1727_CR81","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/s41586-024-07606-7","volume":"632","author":"H Mathys","year":"2024","unstructured":"Mathys H, Boix CA, Akay LA, Xia Z, Davila-Velderrain J, Ng AP, et al. Single-cell multiregion dissection of Alzheimer\u2019s disease. Nature. 2024;632(8026):858\u201368.","journal-title":"Nature"},{"issue":"32","key":"1727_CR82","doi-asserted-by":"publisher","first-page":"11597","DOI":"10.1523\/JNEUROSCI.2180-11.2011","volume":"31","author":"MF Glasser","year":"2011","unstructured":"Glasser MF, Van Essen DC. Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI. J Neurosci. 2011;31(32):11597\u2013616.","journal-title":"J Neurosci"},{"issue":"13","key":"1727_CR83","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1002\/hbm.24638","volume":"40","author":"W Pelkmans","year":"2019","unstructured":"Pelkmans W, Dicks E, Barkhof F, Vrenken H, Scheltens P, van der Flier WM, et al. Gray matter T1-w\/T2-w ratios are higher in Alzheimer\u2019s disease. Hum Brain Mapp. 2019;40(13):3900\u20139.","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"1727_CR84","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13195-020-00679-2","volume":"12","author":"PSJ Weston","year":"2020","unstructured":"Weston PSJ, Poole T, Nicholas JM, Toussaint N, Simpson IJA, Modat M, et al. Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12(1):112.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1727_CR85","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","volume":"23","author":"GB Frisoni","year":"2022","unstructured":"Frisoni GB, Altomare D, Thal DR, Ribaldi F, van der Kant R, Ossenkoppele R, et al. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nat Rev Neurosci. 2022;23(1):53\u201366.","journal-title":"Nat Rev Neurosci"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01727-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01727-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01727-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T04:25:50Z","timestamp":1746505550000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01727-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1727"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01727-5","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All donors had signed an informed consent for brain donation and the use of materials and clinical information for research purposes. The procedures for brain tissue collection of NBB and NABCA have been approved by the Medical Ethical Committee of Amsterdam UMC, Vrije Universiteit Amsterdam.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Laura E. Jonkman reports financial support was provided by Topsector Life Sciences & Health - Topconsortium Kennis en Innovatie (LSH-TKI). Wilma D.J. van de Berg reports financial support was provided by Health Holland, Horizon Europe, Hoffman-La Roche and Genentech. reports relationships with Roche Tissue Diagnositcs, Discoveric Bio and AC Immune that includes: contract research. Reports relationships with Hoffmann-La Roche and Prothena that includes: non-financial support in the form of research consumables. Frederik Barkhof reports relationships with Biogen, Merck, Eisai, and Prothena that include: steering committee or Data Safety Monitoring Board membership. Relationships with Combinostics, Scottish Brain Sciences, and Alzheimer Europe that include: advisory board membership. Relationships with Roche, Celltrion, Rewind Therapeutics, Merck, and Bracco that include: consulting. Relationships with ADDI, Merck, Biogen, GE Healthcare, and Roche that include: research agreements. reports a relationship with NIHR University College London Hospitals Biomedical Research Centre that includes: employment. Relationships with Queen Square Analytics LTD that include: Co-founder and shareholder. Femke\u00a0H. Bouwman reports relationship with Optina Dx and Optos that include: contract research. Reports relationships with biogen that include: paid expert testimony. Reports relationships with Roche that include: speaking and lecturing fees. Elizabeth Gordon, Nicolas Guizard and Thomas Jubault are employees at Qynapse, which holds the IP and rights to the algorithms employed by QyScore in the image analysis used for the manuscript. Jeroen J.M. Hoozemans is employed by F. Hoffmann-La Roche. Baayla D.C. Boon functions as the Programs Chair of the Atypical Alzheimer\u2019s Disease Professional Interest Area, organized by Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART). Authors not mentioned here declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}